[(2S)-2-methyl-4-[[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]methyl]pyrrolidin-1-yl]-phenylmethanone
C23H23N5O — CID 118682966
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2S)-2-methyl-4-[[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]methyl]pyrrolidin-1-yl]-phenylmethanone
[(2S)-2-methyl-4-[[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]methyl]pyrrolidin-1-yl]-phenylmethanone (PubChem CID 118682966) has the molecular formula C23H23N5O and a molecular weight of 385.47 g/mol. Its IUPAC name is [(2S)-2-methyl-4-[[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]methyl]pyrrolidin-1-yl]-phenylmethanone.
Molecular Properties
| Compound Name | [(2S)-2-methyl-4-[[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]methyl]pyrrolidin-1-yl]-phenylmethanone |
|---|---|
| PubChem CID | 118682966 |
| Molecular Formula | C23H23N5O |
| Molecular Weight | 385.47 g/mol |
| Exact Mass | 385.19 |
| IUPAC Name | [(2S)-2-methyl-4-[[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]methyl]pyrrolidin-1-yl]-phenylmethanone |
| SMILES | C[C@H]1CC(Cn2cnc3cc(-c4cn[nH]c4)ccc32)CN1C(=O)c1ccccc1 |
| InChI | InChI=1S/C23H23N5O/c1-16-9-17(14-28(16)23(29)18-5-3-2-4-6-18)13-27-15-24-21-10-19(7-8-22(21)27)20-11-25-26-12-20/h2-8,10-12,15-17H,9,13-14H2,1H3,(H,25,26)/t16-,17?/m0/s1 |
| InChIKey | XVKSAQPHWOIGHF-BHWOMJMDSA-N |
| XLogP | 3.98 |
| TPSA | 66.81 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 385.47 |
| LogP ≤ 5 | 3.98 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118682966 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.